Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in adolescents, bolstering ...

The global vaccine alliance Gavi says it will buy 500,000 doses of vaccine against mpox to fight outbreaks of the disease in ...

The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17.

With the outbreak of Mpox in several countries, the demand for vaccines has increased. The vaccine, administered as a 2-dose ...

With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.

The decision is a crucial step in getting shots to the Democratic Republic of Congo, the center of the outbreak.

The global vaccine group Gavi will buy 500,000 doses of Bavarian Nordic's mpox vaccine, its first purchase of the shot to ...

The European Medicines Agency (EMA) has approved the use of Bavarian Nordic’s mpox vaccine in adolescents, increasing the ...

The World Health Organization and partners on Friday set up a scheme to help bring mpox vaccines, tests and treatments to the ...

The World Health Organization says it has granted its first authorization for use of a vaccine against mpox in adults, ...

The World Health Organization Friday approved MVA-BN as the first mpox vaccine added to its pre-qualification list.

The announcement marks the first mpox vaccine to be added to the WHO's prequalification list to facilitate timely access and ...